SpeeDx PlexPCR® SARS-CoV-2
SpeeDx PlexPCR® SARS-CoV-2 is a dual-target, single-well, multiplex reverse transcriptase qPCR test for the detection of COVID-19 causing coronavirus (SARS-CoV-2) plus RNA internal control.
As SARS-CoV-2 continues to mutate, giving rise to variants potentially impacting diagnostic testing, laboratories need continued confidence in the results they are reporting. SpeeDx routinely monitor the performance of the PlexPCR® SARS-CoV-2 assay against emerging variants to ensure your laboratory can continue to report patient test data with no hesitation.
Security of supply with PlexPCR®
Our unique technology de-couples the detection probe from the target sequence. SpeeDx routinely produce and stockpile large volumes of test reagents to support high volume ordering fluctuations, ensuring no interruptions to your daily laboratory testing.
Clinically relevant turnaround times
Conserved dual target sequence not impacted by current circulating variants, eliminating the need for repeat or confirmation testing by sequencing.
Compatible with robotic liquid handlers including PurePrep FR, an automated and intuitive instrument that alleviates laboratory staffing pressures or constraints.
- Roche LightCycler® 480 Instrument II (LC480 II)
- Bio-Rad CFX96™> Dx (CFX96 Dx)
- Bio-Rad CFX96™ Touch™ (CFX96 Touch)
- Products are shipped on dry ice or ice gel packs.
- For In Vitro Diagnostic use
- Well 1: ORF1ab, RdRp, RNA internal control
- Nasopharyngeal swabs